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Abstract 
Objective: A descriptive study was carried out to determine the significance of IgG-affinity in the 
serological diagnosis of rubella infections in pregnancy.  
Materials and methods: A total of 92 pregnant women who had never received antirubella vaccines were 
recruited by simple random selection and did not exceed 24 weeks of gestation were recruited from the 
antenatal clinics of the University of Ilorin Teaching Hospital. Rubella virus-specific IgG, IgG-affinity and 
IgM were tested, using the Indirect ELISA methods. 
Results: IgG-Affinity tests showed that 2 (2.2%) out of the 92 pregnant women, who were in their first 
and second trimester pregnancies respectively, had primary Rubella infections, while 1 (1.1%) 
primigravidae had a re-infection with rubella virus. It was also discovered that out of the 13 multigravid 
subjects that reported to have lost previous pregnancies, 2 (15.4%) cases may have been due to rubella 
infections that occurred during organogenesis. 
Conclusion: Although the isolation of the whole virus or the viral nucleic material is the best basis for 
diagnosis, IgG-affinity is a proven supplementary serological diagnosis, to distinguish reinfection or viral 
persistence from primary exposure for prompt and accurate diagnosis. This is necessary for proper 
counselling of pregnant women especially in low economies where molecular diagnosis may not be 
affordable. 
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Introduction1 
Rubella virus is the monotypic agent of rubella (1). 
Viral particles are spread through airborne droplets, 
                                                 
Correspondence: 
Oluwapelumi Olufemi Adeyemi, School of Molecular and 
Cellular Biology, and Astbury Centre for Structural Molecular 
Biology, Faculty of Biological Sciences, University of Leeds, 
Leeds, LS2 9JT. United Kingdom.  
Email: peluwa@yahoo.com, bsooa@leeds.ac.uk 
contact with oral-pharyngeal secretion of infected 
persons and vertically from infected mother to foetus 
during pregnancy (2, 3, 1). Rubella remains the mildest 
of viral exanthems in adults and may remain sub-
clinical in 25% to 50% of cases (4, 5). Acute infections 
that occur in early pregnancy may induce foetal death 
or congenital malformations in the foetus, mostly 
affecting the brain, heart, eyes and ears (2). 
Rubella has an average incubation period of  
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12 – 18 days but can extend to 23 days (3, 5). The 
infectious period of the virus is from 7 days before to 
5 – 7 days after the onset of rash (2). Virions invoke a 
serological response that is detectable at the onset of 
its characteristic rash and evolves over the next few 
weeks (6). Viral-specific IgM antibodies are first 
detected 10 days post infection, and peaks at about 4 
weeks post infection and may persist for more than 7 
months after acute infections (6). Three weeks after 
infection, anti-rubella virus antibodies are present in 
all immunoglobulin classes, including IgG, IgA, IgD, 
and IgE (6). At early stages of primary infection, anti-
rubella IgG antibodies have a low antigenic affinity; 
this however matures progressively over the next 3 
months (6). 
Differential diagnosis of rubella infections 
remains unreliable (7). Currently, laboratory 
confirmation of suspected cases is based on the 
detection of Rubella virus-specific IgM in a single 
serum sample collected soon after the onset of 
symptoms (8, 6). However, a positive IgM result may 
not always the onset of a primary infection. Re-
infections are generally asymptomatic and are 
detected by serological investigations (7, 6). 
Although reasons for re-infections have not been 
clearly defined, cases associated with viraemia do not 
seem to be due to a defective immunologic response. 
However, viral strains from cases of reinfection do 
not seem to differ from other strains (8). 
Studies carried out amongst pregnant women in 
Nigeria have revealed prevalence rates of 68.5% and 
76% in two south-western (9, 10), 16.3% in a North-
central region (2), and 54.1% in a North-western 
region (11). Despite the development of successful 
vaccines over four decades ago (7, 8), the global 
burden of disease as a result of Congenital rubella 
syndrome remains a major concern (3, 12). However 
this could, be significantly reduced by immunization 
and diagnostically-informed antenatal counselling (2). 
This study was designed to determine the 
significance of IgG-avidity testing in the serologic 
diagnosis of antenatal rubella. 
Materials and methods 
A descriptive study was carried out on a cohort group 
of 92 pregnant women attending the Antenatal clinics 
at the University of Ilorin Teaching Hospital (UITH), 
Ilorin, Nigeria. Ethical approval was obtained from 
the Ethical Committee of the University of Ilorin 
Teaching Hospital. An informed consent form was 
signed by each participant. Selection criteria included 
pregnant women in their first and second trimesters 
of pregnancy, and had never received antirubella 
vaccines. Pregnant women above 24 weeks of 
gestation, including other pregnant women who were 
not registered at, nor attended the antenatal clinics of 
UITH were excluded from this study. 
A structured questionnaire was designed and 
standardised. Data was collected by 3 trained 
research assistants through structured interviews. 
Three millilitres of blood were collected from the 
subjects by Venepuncture into labelled sterile 
sample tubes and allowed to clot undisturbed at 
room temperature. Sera were separated by 
centrifugation at 3,000 revolutions per minute (rpm) 
for 5 minutes and stored in 3 serum vial aliquots at -
20oC until analyses. 
Sera were tested for Rubella virus-specific IgM, 
IgG and IgG-avidity antibodies by indirect 
quantitative Enzyme-Linked Immunosorbent Assay 
(ELISA) techniques. This was carried out, using the 
SERION ELISA classic Rubella Virus IgG/IgM kit, 
manufactured by SERION® Immunologics, 
Friedrich-Bergius-Ring 19, 97076, Würzburg, 
Germany. IgG test results were interpreted as a ratio 
of the sample optical density (OD) and the sample 
rate/cut-off. OD was read within 60 minutes at 405 
nm against the substrate blank, while reference wave 
length between 620 nm and 690 nm. Cut-off values 
included, <0.30 U/ml = negative; 0.30–0.55 U/ml 
= Borderline; and >0.55 U/ml = positive. IgM test 
results were interpreted similarly as follows: 
<0.135U/ml = negative; 0.135–0.230 U/ml = 
Borderline; and >0.230 U/ml = positive. The controls 
and the calibrators passed the validation check 
recommended by the manufacturers of both the IgG 
and the IgM kits.  
The avidity of IgG for rubella virus was also by 
indirect quantitative ELISA, but measured as a 
percentage ratio of the OD values of two IgG set-ups 
(i.e. with and without 35mM diethylamine). This was 
also carried out according to the manufacturer’s validity 
ranges as displayed on the batch-specific quality control 
certificate, and interpreted as Low (<45%), Borderline 
(>45%<50%) and High (>50%), representing recent 
infections (less than 12 weeks), Ongoing/ progressive 
infection, and Long-past infection (over 12 weeks) or a 
re-infection respectively. 
AI (%) =୓ୈ	୵ୣ୪୪ୱ	ୱ୭ୟ୩ୣୢ	୵୧୲୦	ଷହ	୫୑	ୈ୉୅	୓ୈ	୵ୣ୪୪ୱ	ୱ୭ୟ୩ୣୢ	୵୧୲୦	୵ୟୱ୦	ୠ୳୤୤ୣ୰ × 100 
Data entry was with the SPSS 11 software. Data 
was statistically tested at a critical level for statistical 
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significance of 95% (p=0.05) using the Chi-square 
and 95% Confidence Interval. 
Results 
Of the 92 pregnant women that participated in the 
study, 50 (54.4%) were multigravid, 13 (14.1%) 
had history of previous pregnancy losses (all of 
which occurred in the first and second trimesters of 
pregnancy), while 39 (42.4%) had living children 
(figure 1). Results further revealed a directly 
proprtional relationship between age and 
gestational period amongst the participants.  
A total of 15 pregnant women had detectable 
levels of Rubella virus-specific IgG and IgM 
antibodies in their sera. Table 1 shows the clinical 
history and diagnostic results of the 15 (16.3%) 
participants who tested positive to the presence of 
antirubella IgG and IgM antibodies in their sera. Of 
the 13 pregnant women who had lost previous 
pregnancies, 2 tested positive for the presence of 
antirubella IgG antibodies in their sera, while 1 had a 
borderline antibody test result. 
Among the 15 pregnant women whose sera tested 
positive for the for antirubella IgM and IgG 
antibodies, 7 (46.7%) had high IgG-Avidity levels, 1 
(6.7%) had a moderate IgG-Avidity level, 5 (33.3%) 
had low IgG-Avidity levels, while 2 (13.3%) had no 
IgG-avidity. Furthermore, there was an inversely 
proportional relationship between age bracket and 
antirubella IgG antibodies (y = -0.667x + 22.001; 
r2 = 0.0029; p=0.47) and also between gestational period 
and the IgG-Avidity levels (y = -2.3017x + 106.87;  
r2 = 0.0021; p=0.46). Multiple symptoms were 
however reported. 
Figures 2 and 3 show the relationship between 
clinical Symptoms and Rubella Virus-specific IgG 
and IgM Antibodies respectively. 
Discussion  
The detection of Rubella virus-specific IgG antibody 
in the sera of 14 (15.22%) of the pregnant women 
(p<0.05) confirmed previous exposure to the virus 
(13), since, none of the pregnant women that 
participated in this study had ever received 
antirubella vaccines. The detection of rubella virus-
specific IgM antibodies in the sera of 3 (3.26%) of 
the 92 pregnant women confirms that rubella 
infection was ongoing in those pregnant women (2). 
Such infections possibly occurred at least 10 days 
earlier (6). Detection of IgM antibodies was reported 
as positive and borderline – which highlights the 
course of the ongoing infection. The two borderline 
IgM test results indicate the possibility of an ongoing 
infection that was captured after about four months 
and at least 10 days since the infection occurred 
respectively (6).  
 
 
Figure 1: Pregnancy History 
This figure shows the pregnancy history of the study subjects, including previous pregnancy losses – most of which 
occurred around the 10th week of gestation. 
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Table 1: Patient's Diagnosis Result and Test History 
Patient Details Age (Years) 
Gestation 
(Weeks) 
Rubella Serology 
IgM IgG Avidity 
1. Primigravid. No history of rubella vaccination or contact 30 24 + ++ High 
2. Primigravid. Developed rash two weeks earlier. History of pregnancy loss at 6 weeks gestation. 26 20 - ++ High 
3. Primigravid. No rash or known contact. No history of rubella vaccination. 25 16 - ++ Low 
4. Primigravid. No history of rubella vaccination. History of pregnancy loss 28 23 - ++ High 
5. Primigravid. No rash or known contact. No history of rubella vaccination 29 16 - ++ Nil 
6. Primigravid. No rash or known contact. No history of rubella vaccination. Complained of joint pains in legs 23 16 - + High 
7. Primigravid. Rashes, 6-week old fever with joint pains. No history of rubella vaccination. 27 8 - + High 
8. Multigravid. No rash or known contact. No history of rubella vaccination 23 18 - + High 
9. Multigravid. No rash or known contact. No history of rubella vaccination 30 24 - + Low 
10. Multigravid. History of pregnancy at 20 weeks of gestation. No history of rubella vaccination. 29 26 - + Low 
11. Multigravid. No rash or known contact. No history of rubella vaccination. 35 12 ++ ++ Low 
12. Primigravid. No rash or known contact. No history of rubella vaccination 20 20 - + Moderate
13. Multigravid. Complained of fever with joint pains. No rash or known contact. No history of rubella vaccination 38 12 - + High 
14. Primigravid. No rash or known contact. No history of rubella vaccination 28 24 - + Low 
15. No history of rubella vaccination. 34 16 + - Nil 
- Negative, + Borderline, ++ Positive 
 
 
Figure 2: Correlation between Age Bracket, IgG and IgG-Avidity 
Age Bracket and IgG: Linear Regression (y = -0.667x + 22.001) (r2 = 0.0029; p = 0.047) 
Age Bracket and IgG Avidity: Linear Regression (y = 0.549x + 56.357) (r2 = 0.0015; p = 0.48) 
IgG Avidity in Antenatal Rubella Diagnosis 
 Journal of Family and Reproductive Health  jfrh.tums.ac.ir Vol. 7, No. 3, September 2013       135 
 
Figure 3: Correlation between Gestational Period, IgG and IgG-Avidity 
Gestation and IgG: Linear Regression (y = 0.0466x + 11.644) (r2 = 0.0405; p = 0.044) 
Gestation and IgG Avidity: Linear Regression (y = -2.3017x + 106.87) (r2 = 0.0021; p = 0.46) 
 
 
Although most of the pregnant women that 
participated in this study had living children (Figure 
1), 13 (14.1%) reported pregnancy losses that could 
have occurred during organogenesis. Out of the 13 
who had lost previous pregnancies, 2 had positive 
IgG antibody tests, while 1 had a borderline antibody 
test. This result shows that the pregnancy losses could 
have been a result of Rubella infections in the 2 
women with high IgG avidity levels. However, the 
pregnant woman with borderline IgG and low avidity 
must have lost her previous pregnancy to other 
teratogens (biological or chemical), however, 
previous studies carried out have shown that the 
development of IgG often coincides with diminished 
levels of serum IgM (6); although, this may be 
confirmed by further laboratory investigations (3). 
As presented in Table 1, clinical symptoms 
reported by the pregnant women are descriptive of 
Rubella virus infections at various stages of 
pathogenesis (5, 3) Although lymphadenopathy and 
maculopapula rash were the least observed symptoms 
amongst the subjects, the predominance of fever 
cases observed (Table 1) conforms to previous 
studies that showed that the most common symptoms 
of rubella (lymphadenopathy, erythematous rash and 
low-grade fever) can be readily confused with similar 
illnesses associated with maculopapula rash caused 
by other common viral and non-viral pathogens or 
even some drugs (6). Invariably, clinical diagnosis 
has been proven unreliable (7) as observed in the 
discordant laboratory diagnostic results (Table 1). 
This irrefutably confirms the evidence of subclinical 
Rubella virus infections (3, 5) as observed in the 
pregnant women whose sera tested positive for 
rubella virus-specific IgM antibodies but showed no 
clinical symptoms. 
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A positive IgM result may not necessarily mean a 
primary infection in every case; therefore, anti-
rubella IgG avidity assay was used in differentiating 
between primary and re-infection (14, 3). Seven of 
the pregnant women that participated in the study 
were diagnosed to have past infections, 1 (1.1%) of 
them had infections that occurred over two weeks ago 
and were ongoing, 3 (3.3%) had primary infections 
that occurred at least two weeks prior to the 
laboratory test while 2 (2.2.%) had recent infections 
occurring in less than two weeks. 
A confirmed case of rubella infection in the screened 
pregnant women is the laboratory diagnosis of the 
presence of IgM in the sera of the screened pregnant 
women. However, immunological responses to rubella 
infections have various implications such that a 
Borderline IgM serological test result implies that: 
1. A recent rubella infection occurred because 
antirubella IgM is detected first, 10 days post 
infection during which antirubella IgG 
immunoglobulin have not been produced and 
therefore are not detected in the patient serum (6); 
2. An acute rubella infection began less than two 
weeks ago, and the host (IgM) immune response is 
still being developed because; antirubella IgM peaks 
at about 4 weeks post infection. This can be best 
confirmed if the host IgG test is positive and IgG 
avidity index is very low because; by three weeks 
post infection, anti-rubella virus IgG antibodies are 
present (6); 
3. An acute rubella infection occurred within the 
last seven months during which the IgM may be 
thinning out and IgG avidity maturing. A 
confirmatory test however is the antirubella IgG 
positive test with a moderate avidity index (6); 
4. A secondary rubella infection (i.e. rubella 
reinfection) has occurred (excluding the possibility of 
residual IgM months or years after the primary 
infection) if antirubella IgG test is positive with a 
High avidity index (13). This is because a natural 
rubella infection normally confers lifelong immunity. 
Therefore, supplementary measurement of IgM 
together with the measurement of antirubella specific 
IgM is combined to distinguish reinfection or viral 
persistence from primary exposure (6). 
Primary Rubella Virus Infection 
It was observed that the sera of a 34-year old subject, 
who was in her second trimester of pregnancy, had 
borderline antirubella IgM and was negative for 
antirubella IgG. This indicates the possibility of a 
recent rubella infection, which may have occurred 
about ten days prior to the laboratory serological test 
(6). Only one subject however tested positive for 
antirubella IgM with a positive antirubella IgG as 
well, and a very low IgG avidity index; thus, 
implying that the infection was acute and began less 
than two weeks from date of sample collection. The 
subject’s histories further revealed that she is a 35-
year old married multigravidae in her first trimester 
of pregnancy. She has never been immunized against 
Rubella virus, without a living child. She never had 
an abortion (induced or spontaneous). 
Secondary Rubella Virus Infection (i.e. reinfection) 
It was observed that two of the screened pregnant 
women had borderline Rubella virus-specific IgM 
antibodies in their sera. However, one of these 
subjects also tested positive for Rubella virus-specific 
IgG antibodies with a High IgG-Avidity Index; thus 
indicating the possibility of a reinfection in that 
patient. The medical history of this patient further 
revealed that, she was a 30-year old primigravida 
with no history of immunization against rubella virus. 
However, she did not present with any clinical 
symptom of rubella virus infection, this is in 
accordance with previous studies that showed that 
reinfections are generally asymptomatic and are 
recognised by serological investigations (7). Further 
still, such occurrences pose an extremely small risk of 
foetal damage as a result of the high avidity 
antirubella IgG. 
Acute rubella virus infections that occur in early 
pregnancy may induce foetal death or congenital 
rubella syndrome (1, 15, 16). Unfortunately, at early 
stages of primary Rubella virus infections, IgG is of 
low avidity, maturing gradually over three months 
(6), thus making IgG and IgM detection inaccurate 
for complete diagnosis. Detection of this low IgG 
avidity together with antiviral IgA has been 
promoted as an alternative or supplement to the 
measurement of rubella specific IgM, to distinguish 
reinfection or viral persistence from primary 
exposure (6). This has further been established 
through the cases presented in this study to aid 
prompt and accurate diagnosis, which is necessary 
for proper counselling of pregnant women. 
Significance of IgG Avidity 
Of the 14 pregnant women whose sera tested positive 
for IgG antibodies, 3 were observed to have clinical 
rubella symptoms. Although a correlation between 
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serum IgG and clinical symptoms was statistically 
significant for all symptoms, further serology showed 
that these three women, who were between 8 – 16 
weeks of gestation, had no laboratory diagnostic 
evidence of ongoing rubella infections because, their 
serum IgG-Avidity index levels were high. 
Furthermore, IgM antibodies tested negative; thus 
implying that the clinical symptoms observed were 
differential. 
This result also shows that the pregnancy losses 
could have been a result of Rubella infections in the 2 
women with high IgG avidity levels 
The woman with borderline IgG and low avidity 
must have lost her previous pregnancy to other 
teratogens (biological or chemical), however, 
previous studies carried out have shown that the 
development of IgG often coincides with diminished 
levels of serum IgM (17) 
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